...
首页> 外文期刊>BMC Infectious Diseases >Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
【24h】

Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

机译:有希望的地方:在乌兹别克斯坦的卡拉卡尔帕克斯坦进行的一项定性研究,研究了患者对耐多药结核病治疗的依从性

获取原文

摘要

Background Treatment for multi-drug resistant tuberculosis (MDR-TB) is lengthy, has severe side effects, and raises adherence challenges. In the Médecins Sans Frontières (MSF) and Ministry of Health (MoH) programme in Karakalpakstan, Uzbekistan, a region with a high burden of MDR-TB, patient loss from treatment (LFT) remains high despite adherence support strategies. While certain factors associated with LFT have been identified, there is limited understanding of why some patients are able to adhere to treatment while others are not. We conducted a qualitative study to explore patients’ experiences with MDR-TB treatment, with the aim of providing insight into the barriers and enablers to treatment-taking to inform future strategies of adherence support. Methods Participants were purposively selected. Programme data were analysed to enable stratification of patients by adherence category, gender, and age. 52 in-depth interviews were conducted with MDR-TB patients ( n =?35) and health practitioners ( n =?12; MSF and MoH doctors, nurses, and counsellors), including five follow-up interviews. Interview notes, then transcripts, were analysed using coding to identify emerging patterns and themes. Manual analysis drew upon principles of grounded theory with constant comparison of codes and categories within and between cases to actively seek discrepancies and generate concepts from participant accounts. Ethics approval was received from the MoH of the Republic of Uzbekistan Ethics Committee and MSF Ethics Review Board. Results Several factors influenced adherence. Hope and high quality knowledge supported adherence; autonomy and control enabled optimal engagement with treatment-taking; and perceptions of the body, self, treatment, and disease influenced drug tolerance. As far as we are aware, the influence of patient autonomy and control on MDR-TB treatment-taking has not previously been described. In particular, the autonomy of married women around treatment-taking was potentially undermined through their societal position as daughter-in-law, compromising their ability to adhere to treatment. Patients’ engagement with and adherence to treatment could be hindered by hierarchical practitioner-patient relationships that displaced authority, ownership, and responsibility from the patient. Conclusions Our findings reinforce the need for an individualised and holistic approach to adherence support with engagement of patients as active participants in their care who feel ownership and responsibility for their treatment.
机译:背景耐多药结核病(MDR-TB)的治疗时间长,副作用严重,并增加了依从性。在乌兹别克斯坦卡拉卡帕克斯坦的MédecinsSansFrontières(MSF)和卫生部(MoH)计划中,耐多药结核病负担很重,尽管有依从性支持策略,但患者因治疗失误(LFT)仍然很高。虽然已经确定了与LFT相关的某些因素,但对于为什么有些患者能够坚持治疗而另一些患者却不能坚持治疗的理解仍然有限。我们进行了定性研究,以探讨患者在耐多药结核病治疗方面的经验,目的是深入了解进行治疗的障碍和促成因素,从而为坚持治疗的未来策略提供依据。方法有目的地选择参与者。对计划数据进行了分析,以根据依从类别,性别和年龄对患者进行分层。对耐多药结核病患者(n = 35)和医疗从业人员(n = 12; MSF和卫生部的医生,护士和咨询师)进行了52次深度访谈,包括五次随访。采访笔记,然后是笔录,使用编码进行了分析,以识别新兴的模式和主题。手动分析借鉴了扎根理论的原理,并不断比较案例内部和案例之间的代码和类别,以积极寻求差异并从参与者账户中产生概念。道德规范得到了乌兹别克斯坦共和国道德规范委员会和无国界医生道德规范审查委员会的批准。结果有几个因素影响依从性。希望和高质量的知识支持坚持;自主和控制使与治疗的最佳接触成为可能;身体,自我,治疗和疾病的感知影响了药物耐受性。据我们所知,患者自主性和控制对耐多药结核病治疗的影响以前没有被描述过。尤其是,已婚妇女在接受daughter治时的社会地位可能会削弱他们在接受治疗方面的自主权,从而损害了她们坚持治疗的能力。分级的从业人员与患者之间的关系可能会阻碍患者参与和坚持治疗,从而使患者的权威,所有权和责任感错位。结论我们的发现加强了对个体依从性和整体性方法进行依从性支持的需求,需要患者积极参与治疗并感受到治疗的主人翁和责任感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号